UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 28,
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Nymox Pharmaceutical Charts.
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Nymox Pharmaceutical Charts.

Nymox Pharmaceutical Corp News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 28 March 2024 (1 month ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)
Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Friday 8 September 2023 (8 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 25 July 2023 (9 months ago) • Edgar (US Regulatory)
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
Tuesday 25 July 2023 (9 months ago) • GlobeNewswire Inc.
Nymox Reports on U.S. Patent Issuances
Tuesday 18 July 2023 (10 months ago) • GlobeNewswire Inc.
Nymox Update
Thursday 13 July 2023 (10 months ago) • GlobeNewswire Inc.
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
Wednesday 12 July 2023 (10 months ago) • GlobeNewswire Inc.
NYMOX Update
Friday 7 July 2023 (10 months ago) • GlobeNewswire Inc.
Nymox Delisting from NASDAQ
Wednesday 5 July 2023 (10 months ago) • GlobeNewswire Inc.
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 29 June 2023 (10 months ago) • Edgar (US Regulatory)
Nymox Provides Current Update
Wednesday 10 May 2023 (12 months ago) • GlobeNewswire Inc.

More Nymox Pharmaceutical Corp News Articles